Papers (last 5 years)

 

Top 10

  1. Muzet A. Environmental noise, sleep and health. Sleep Med Rev. 2007; 11(2):135-42.
  2. Staner L. Comorbidity of insomnia and depression. Sleep Med Rev 2010;14:35-46.
  3. Grenèche J, Sarémi M, Erhardt C, Hoeft A, Eschenlauer A, Muzet A, Tassi P. Severity of obstructive sleep apnoea/hypopnoea syndrome and subsequent waking EEG spectral power. Eur Respir J 2008;32:705-709.
  4. Schunck T, Erb G, Mathis A, Gilles C, Namer IJ, Hode Y, Demaziere A, Luthringer R, Macher JP. Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety. Neuroimage. 2006; 31(3):1197-208.
  5. Mayer G, Wang-Weigand S, Roth-Schechter B, Lehmann R, Staner C, Partinen M. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia. Sleep. 2009; 32(3):351-60.
  6. Deacon S, Staner L, Staner C, Legters A, Loft H, Lundahl J. Effect of short-term treatment with gaboxadol on sleep maintenance and initiation in patients with primary insomnia. Sleep. 2007; 30(3):281-287.
  7. Al-Shamma HA, Anderson C, Chuang E, Luthringer R, Grottick AJ, Hauser E, Morgan M, Shanahan W, Teegarden BR, Thomsen WJ, Behan D. Nelotanserin, a Novel Selective Human 5-Hydroxytryptamine2A inverse Agonist for the Treatment of Insomnia. J Pharmacol Exp Ther. 2010;332:281-290.
  8. Dunbar G, Boeijinga PH, Demazières A, Cisterni C, Kuchibhatla R, Wesnes K, Luthringer R. Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers. Psychopharmacology. 2007; 191(4):919-929.
  9. Lundahl J, Staner L, Staner C, Loft H, Deacon S. Short treatment with Gaboxadol improves sleep maintenace and enhances slow wave sleep in adult patients with primary insomnia. Psychopharmacology 2007;195:139-146.
  10. Luthringer R, Staner L, Noel N, Muzet M, Gassmann-Mayer C, Talluri K, Cleton A, Eerdekens M, Battisti WP, Palumbo JM. A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended release tablets on sleep architecture in patients with schizophrenia. Int Clin Psychopharmacol. 2007; 22(5):299-308.

 

Here are the last years publications to FORENAP expertise fields. For any information related to the subjects of these publications, please do not hesitate to contact us.

 

2010

2009

2008 

2007

 2006

 

 2010

 2009

 

 2008


2007

 

2006